Lv42
530 积分 2024-12-10 加入
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
1天前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
1天前
已完结
中国糖尿病防治指南（2024版
1个月前
已完结
BLOOD GROUP FREQUENCIES IN ADMIRALTY ISLANDERS: FURTHER OBSERVATIONS ON THE FIJIANS AND INDONESIANS AND ON Rh GENE FREQUENCIES IN SOME OTHER RACES
1个月前
已完结
核医学18F-FDG PET/CT报告书写规范
2个月前
已完结
Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris
2个月前
已完结
Diagnosis and treatment of acne inversa/hidradenitis suppurativa in China: an expert consensus statement （2021 version）
3个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
3个月前
已完结
Efficacy and Safety of Admilparant, an LPA1 Antagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
6个月前
已完结
皖公网安备34019202002308
